Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheryl E Koch

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|March 5, 2013
Targeting TRPV1 and TRPV2 for potential therapeutic interventions in cardiovascular diseaseNathan Robbins, Sheryl E Koch, Jack Rubinstein
Progress in Biophysics and Molecular Biology|June 23, 2020
TRPV2 channel-based therapies in the cardiovascular field. Molecular underpinnings of clinically relevant therapiesBrian O'Connor, Nathan Robbins, Sheryl E Koch, et al.
Cardiovascular Toxicology|September 23, 2011
The history and future of probenecidNathan Robbins, Sheryl E Koch, Michael Tranter, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 6, 2007
Coronary effluent from a preconditioned heart activates the JAK-STAT pathway and induces cardioprotection in a donor heartLynn C Huffman, Sheryl E Koch, Karyn L Butler
Scientific Reports|May 18, 2021
Developmental and lifelong dioxin exposure induces measurable changes in cardiac structure and function in adulthoodMatthew de Gannes, Sheryl E Koch, Alvaro Puga, et al.
Journal of Molecular and Cellular Cardiology|September 18, 2002
Calcium cycling, historic overview and perspectives. Role for autonomic nervous system regulationNatalia N Petrashevskaya, Sheryl E Koch, Ilona Bodi, et al.
Frontiers in Physiology|December 6, 2021
Role of Known Transient Receptor Potential Vanilloid Channels in Modulating Cardiac MechanobiologyMichael Miller, Sheryl E Koch, Adam Veteto, et al.
Plos One|January 18, 2023
Tefillin use induces preconditioning associated changes in heart rate variabilitySheryl E Koch, Elyse Martin, Amitesh Verma, et al.
Pharmacology Research & Perspectives|January 12, 2023
A humanized anti-cocaine mAb antagonizes the cardiovascular effects of cocaine in ratsSheryl E Koch, Jordan A Marckel, Jack Rubinstein, et al.
The Journal of Clinical Investigation|December 3, 2005
The L-type calcium channel in the heart: the beat goes onIlona Bodi, Gabor Mikala, Sheryl E Koch, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Translational Research : the Journal of Laboratory and Clinical Medicine|March 5, 2013
Targeting TRPV1 and TRPV2 for potential therapeutic interventions in cardiovascular diseaseNathan Robbins, Sheryl E Koch, Jack Rubinstein
Progress in Biophysics and Molecular Biology|June 23, 2020
TRPV2 channel-based therapies in the cardiovascular field. Molecular underpinnings of clinically relevant therapiesBrian O'Connor, Nathan Robbins, Sheryl E Koch, et al.
Cardiovascular Toxicology|September 23, 2011
The history and future of probenecidNathan Robbins, Sheryl E Koch, Michael Tranter, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 6, 2007
Coronary effluent from a preconditioned heart activates the JAK-STAT pathway and induces cardioprotection in a donor heartLynn C Huffman, Sheryl E Koch, Karyn L Butler
Scientific Reports|May 18, 2021
Developmental and lifelong dioxin exposure induces measurable changes in cardiac structure and function in adulthoodMatthew de Gannes, Sheryl E Koch, Alvaro Puga, et al.
Journal of Molecular and Cellular Cardiology|September 18, 2002
Calcium cycling, historic overview and perspectives. Role for autonomic nervous system regulationNatalia N Petrashevskaya, Sheryl E Koch, Ilona Bodi, et al.
Frontiers in Physiology|December 6, 2021
Role of Known Transient Receptor Potential Vanilloid Channels in Modulating Cardiac MechanobiologyMichael Miller, Sheryl E Koch, Adam Veteto, et al.
Plos One|January 18, 2023
Tefillin use induces preconditioning associated changes in heart rate variabilitySheryl E Koch, Elyse Martin, Amitesh Verma, et al.
Pharmacology Research & Perspectives|January 12, 2023
A humanized anti-cocaine mAb antagonizes the cardiovascular effects of cocaine in ratsSheryl E Koch, Jordan A Marckel, Jack Rubinstein, et al.
The Journal of Clinical Investigation|December 3, 2005
The L-type calcium channel in the heart: the beat goes onIlona Bodi, Gabor Mikala, Sheryl E Koch, et al.
Pageof 5